Suchergebnisse - "Jo, Youngji"

PubPharm (10)

1

Changes in HIV Treatment Differentiated Care Utilization During the COVID-19 Pandemic in Zambia

enthalten in: bioRxiv.org | 2024

von Jo, Y. | Rosen, S. | Sy, K. | +8

2

A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab : Evusheld) Preventive Treatment for High-Risk Populations Against SARS-CoV-2 in Korea

enthalten in: Journal of Korean medical science | 2023

von Jo, Y. | Kim, S. | Jung, J.

3

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

enthalten in: bioRxiv.org | 2022

von Jo, Y. | Jamieson, L. | Edoka, I. | +7

4

Optimal Social Distancing Policy for COVID-19 Control in Korea : A Model-Based Analysis

enthalten in: Journal of Korean medical science | 2022

von Jo, Y. | Shrestha, S. | Radnaabaatar, M. | +2

5

Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

enthalten in: Epidemiology and health | 2022

von Jo, Y. | Kim, S. | Radnaabaatar, M. | +5

6

Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia : interrupted time series analysis

enthalten in: Journal of the International AIDS Society | 2021

von Jo, Y. | Rosen, S. | Sy, K. | +8

7

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa

enthalten in: Open forum infectious diseases | 2021

von Jo, Y. | Jamieson, L. | Edoka, I. | +7

UpdateOf: medRxiv. 2020 Sep 27;:. - PMID 32995824

8

Changes in HIV treatment differentiated care uptake during the COVID‐19 pandemic in Zambia : interrupted time series analysis

enthalten in: Journal of the International AIDS Society | 2021

von Jo, Y. | Rosen, S. | Sy, K. | +8

9

Serological testing in addition to PCR screening for the re-opening of American colleges and universities: potential for cost-savings without compromising pandemic mitigation

enthalten in: bioRxiv.org | 2020

von Jo, Y. | Singh, R. | Rao, G. | +2

10

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

enthalten in: medRxiv : the preprint server for health sciences | 2020

von Jo, Y. | Jamieson, L. | Edoka, I. | +7

UpdateIn: Open Forum Infect Dis. 2021 Jan 29;8(3):ofab040. - PMID 33732750

1
[1]